NEW YORK--(BUSINESS WIRE)--The Rosen Law Firm announces that it is investigating potential securities claims …
A stock’s performance during a typical day does not necessarily mean that a stock will break out over a period of time. …
Based on fundamentals, market trends, company events and news, and other factors, equity analysts assign price targets and recommendations to buy or sell a stock. The following graph shows how a survey of multiple analysts recommend …
Oct 27 (Reuters) - Exxon Mobil Corp :Says no plans to make any share repurchases in Q4.Says will grow Permian rig count to 30 - from 20 currently - by end of 2018.Says will drill first 3-mile lateral in Permian by end of year.Says …
Celsion Corporation is an oncology drug development company. The Company's product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for treatment of primary liver cancer …
Celsion (NASDAQ: CLSN) rose 14.75% to $1.40 on Phase 3 ThermoDox® HEAT study presentation. Digital Ally (NASDAQ: DGLY) jumped 12.37% to $8.99. Digital Ally shares have jumped 156.41% over the past 52 weeks, while …
A Shanghai surprise has tripped the buying switch worldwide, with markets everywhere — well, almost everywhere — pushing higher. Some weighty pundits have been jumping on the China bandwagon recently and, after a dismal …
Celsion's (CLSN) pipeline candidate, GEN1, controls ovarian cancer in all patients in the phase Ib study and achieves a historical improvement in progression free survival.
Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international …